NIH-funded research P01 program project

Understanding the Immune System in Post-Treatment Lyme Disease Syndrome

Official title: Immunology of Post-Treatment Lyme Disease Syndrome

Funded at Tufts University Boston · NIH-11184322 · Data updated 2026-11-12

This project aims to understand how the immune system behaves differently in people who continue to have symptoms after Lyme disease treatment compared to those who fully recover.

More Lyme Disease research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionTufts University Boston
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 5, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$1,013,656
NIH project number5P01AI181934-02
Project IDNIH-11184322 on NIH RePORTER

Who could benefit from this research

Could help

This research is for individuals who have been treated for Lyme disease and either continue to experience symptoms or have fully recovered.

Less likely to help

Patients whose symptoms are not related to Post-Treatment Lyme Disease Syndrome may not directly benefit from this specific research.

What this research studies

We are exploring why some individuals continue to experience symptoms even after receiving treatment for Lyme disease, a condition known as Post-Treatment Lyme Disease Syndrome (PTLDS). It is thought that the immune system might play a key role in these ongoing symptoms, similar to what is observed in conditions like fibromyalgia or other long-term effects following infections. Our approach involves comparing immune responses and the cellular makeup of blood samples from patients with PTLDS against those who have fully recovered from Lyme disease. By using advanced methods to examine proteins and gene expression, we hope to pinpoint specific immune system changes that are linked to the persistence of symptoms.

Why it matters

Potential benefit: If successful, this work could lead to new ways to diagnose and treat the persistent symptoms of Post-Treatment Lyme Disease Syndrome.

How similar studies have gone: Previous studies have suggested immune system activation and auto-antibodies in PTLDS, but consistent findings and specific mechanisms are still being sought.

Where this research is happening

  • Tufts University Boston
    Boston, United States
    Active

Researchers

  • Principal investigator: Hu, Linden T — Tufts University Boston
  • Study coordinator: Hu, Linden T

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.